T1	Participants 39 76	women with and without heart disease:
T2	Participants 540 593	women with a history of coronary heart disease (CHD).
T3	Participants 919 967	13 388 women at increased risk for breast cancer
T4	Participants 1112 1148	1048 of whom had prior clinical CHD.